Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ursula Grohmann

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
Journal of Autoimmunity|July 2, 2020
A novel mutation of indoleamine 2,3-dioxygenase 1 causes a rapid proteasomal degradation and compromises protein functionGiada Mondanelli, Valeria Di Battista, Fabrizia Pellanera, et al.
International Journal of Molecular Sciences|April 12, 2022
Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and PitfallsAndrea Mammoli, Elisa Bianconi, Luana Ruta, et al.
Blood|December 13, 2005
Toward the identification of a tolerogenic signature in IDO-competent dendritic cellsCiriana Orabona, Paolo Puccetti, Carmine Vacca, et al.
Nature Communications|May 16, 2013
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathwayClaudia Volpi, Francesca Fallarino, Maria T Pallotta, et al.
Nature|January 11, 2008
Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous diseaseLuigina Romani, Francesca Fallarino, Antonella De Luca, et al.
Transplant Immunology|December 13, 2006
Tryptophan catabolism generates autoimmune-preventive regulatory T cellsFrancesca Fallarino, Ursula Grohmann, Sylvaine You, et al.
Immunobiology|October 4, 2014
LPS-conditioned dendritic cells confer endotoxin tolerance contingent on tryptophan catabolismFrancesca Fallarino, Maria T Pallotta, Davide Matino, et al.
Journal of Cellular and Molecular Medicine|September 13, 2014
Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetesMaria Teresa Pallotta, Ciriana Orabona, Roberta Bianchi, et al.
Diabetes|June 28, 2018
Loss of IDO1 Expression From Human Pancreatic β-Cells Precedes Their Destruction During the Development of Type 1 DiabetesFlorence Anquetil, Giada Mondanelli, Nathaly Gonzalez, et al.
Inflammatory Bowel Diseases|March 11, 2021
Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment Response in Inflammatory Bowel DiseaseRenske W M Pauwels, Elisa Proietti, Christien J van der Woude, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Journal of Autoimmunity|July 2, 2020
A novel mutation of indoleamine 2,3-dioxygenase 1 causes a rapid proteasomal degradation and compromises protein functionGiada Mondanelli, Valeria Di Battista, Fabrizia Pellanera, et al.
International Journal of Molecular Sciences|April 12, 2022
Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and PitfallsAndrea Mammoli, Elisa Bianconi, Luana Ruta, et al.
Blood|December 13, 2005
Toward the identification of a tolerogenic signature in IDO-competent dendritic cellsCiriana Orabona, Paolo Puccetti, Carmine Vacca, et al.
Nature Communications|May 16, 2013
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathwayClaudia Volpi, Francesca Fallarino, Maria T Pallotta, et al.
Nature|January 11, 2008
Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous diseaseLuigina Romani, Francesca Fallarino, Antonella De Luca, et al.
Transplant Immunology|December 13, 2006
Tryptophan catabolism generates autoimmune-preventive regulatory T cellsFrancesca Fallarino, Ursula Grohmann, Sylvaine You, et al.
Immunobiology|October 4, 2014
LPS-conditioned dendritic cells confer endotoxin tolerance contingent on tryptophan catabolismFrancesca Fallarino, Maria T Pallotta, Davide Matino, et al.
Journal of Cellular and Molecular Medicine|September 13, 2014
Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetesMaria Teresa Pallotta, Ciriana Orabona, Roberta Bianchi, et al.
Diabetes|June 28, 2018
Loss of IDO1 Expression From Human Pancreatic β-Cells Precedes Their Destruction During the Development of Type 1 DiabetesFlorence Anquetil, Giada Mondanelli, Nathaly Gonzalez, et al.
Inflammatory Bowel Diseases|March 11, 2021
Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment Response in Inflammatory Bowel DiseaseRenske W M Pauwels, Elisa Proietti, Christien J van der Woude, et al.
Pageof 10